MedPath

Study of Program Interest "Bouge" to Improve the Daily Physical Activity in Processings Treatment of Non-metastatic Breast Cancer

Not Applicable
Conditions
Mobile Health Apps
Breast Cancer
Physical Activity
Interventions
Device: Smartphone application "placebo"
Device: Smartphone equipped with application "bouge" = Coach group
Registration Number
NCT03674515
Lead Sponsor
University Hospital, Brest
Brief Summary

Evaluate the "Bouge" digital program (smartphone application) to increase the daily physical activity of breast cancer patients

Detailed Description

Controlled, randomized, open, prospective, multicentric study, 214 volunteer patients aged between 18 and 70, with breast cancer, at the start of TAXOL treatment, possessing a smartphone, will be recruited and randomized into two groups:

107 in the control group (smartphone application "placebo" = number of steps) 107 will be equipped with the application "Bouge" = coached group

For three months, the patients do their daily physical activity. The "coached" group, through the smartphone application "Bouge", receives computer coaching to increase their physical activity (no direct medical intervention, only notifications and computer pusch).

The control group is not coached by the application (simple display of the number of step)

Recruitment & Eligibility

Status
UNKNOWN
Sex
Female
Target Recruitment
214
Inclusion Criteria

non-metastatic breast cancer start of treatment with TAXOL compatible smartphone

Exclusion Criteria

age metastatic breast cancer

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
placeboSmartphone application "placebo"Smartphone application "placebo"
"Bouge"Smartphone equipped with application "bouge" = Coach groupSmartphone equipped with the application "Bouge"
Primary Outcome Measures
NameTimeMethod
Increased daily physical activity (number of steps) using the smartphone application "BOUGE"12 weeks

The objective is an increase of 3000 steps daily between J 1 and J 90 (an increase of 15 000 steps between S1 and S 12)

Secondary Outcome Measures
NameTimeMethod
Well-being,12 weeks

Scale EORTC QLQ-C30,

Fatigue12 weeks

Scale WHO

Sleep12 weeks

Scale SPIEGEL

Trial Locations

Locations (2)

CHU de Morlaix

🇫🇷

Morlaix, France

CHRU de Brest

🇫🇷

Brest, France

© Copyright 2025. All Rights Reserved by MedPath